Barclays’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $679M | Sell |
1,354,112
-489,971
| -27% | -$235M | 0.13% | 97 |
|
|
2026
Q1 | $906M | Buy |
1,844,083
+174,349
| +10% | +$94.6M | 0.22% | 65 |
|
|
2025
Q4 | $968M | Sell |
1,669,734
-407,249
| -20% | -$230M | 0.23% | 57 |
|
|
2025
Q3 | $1.01B | Buy |
2,076,983
+507,167
| +32% | +$236M | 0.22% | 58 |
|
|
2025
Q2 | $636M | Buy |
1,569,816
+74,213
| +5% | +$31M | 0.15% | 89 |
|
|
2025
Q1 | $744M | Buy |
1,495,603
+195,370
| +15% | +$106M | 0.21% | 67 |
|
|
2024
Q4 | $676M | Sell |
1,300,233
-408,296
| -24% | -$224M | 0.19% | 57 |
|
|
2024
Q3 | $1.06B | Buy |
1,708,529
+106,002
| +7% | +$62.7M | 0.28% | 37 |
|
|
2024
Q2 | $886M | Buy |
1,602,527
+81,056
| +5% | +$46.4M | 0.27% | 49 |
|
|
2024
Q1 | $884M | Sell |
1,521,471
-11,803
| -0.8% | -$6.62M | 0.31% | 50 |
|
|
2023
Q4 | $814M | Buy |
1,533,274
+225,176
| +17% | +$109M | 0.3% | 49 |
|
|
2023
Q3 | $662M | Buy |
1,308,098
+130,394
| +11% | +$69.5M | 0.41% | 39 |
|
|
2023
Q2 | $614M | Buy |
1,177,704
+331,790
| +39% | +$179M | 0.39% | 47 |
|
|
2023
Q1 | $488M | Sell |
845,914
-528,789
| -38% | -$298M | 0.22% | 43 |
|
|
2022
Q4 | $757M | Buy |
1,374,703
+345,588
| +34% | +$183M | 0.34% | 34 |
|
|
2022
Q3 | $522M | Buy |
1,029,115
+46,070
| +5% | +$25.8M | 0.57% | 24 |
|
|
2022
Q2 | $534M | Sell |
983,045
-41,717
| -4% | -$23M | 0.33% | 41 |
|
|
2022
Q1 | $605M | Sell |
1,024,762
-147,884
| -13% | -$85M | 0.47% | 34 |
|
|
2021
Q4 | $782M | Buy |
1,172,646
+68,711
| +6% | +$42.9M | 0.29% | 63 |
|
|
2021
Q3 | $631M | Buy |
1,103,935
+246,875
| +29% | +$135M | 0.28% | 56 |
|
|
2021
Q2 | $432M | Buy |
857,060
+62,084
| +8% | +$29.3M | 0.2% | 69 |
|
|
2021
Q1 | $363M | Buy |
794,976
+146,403
| +23% | +$69.9M | 0.19% | 73 |
|
|
2020
Q4 | $302M | Sell |
648,573
-140,495
| -18% | -$65.9M | 0.16% | 96 |
|
|
2020
Q3 | $348M | Buy |
789,068
+562,552
| +248% | +$232M | 0.21% | 75 |
|
|
2020
Q2 | $82.1M | Sell |
226,516
-167,875
| -43% | -$56.3M | 0.06% | 227 |
|
|
2020
Q1 | $112M | Sell |
394,391
-227,238
| -37% | -$71.7M | 0.09% | 143 |
|
|
2019
Q4 | $202M | Buy |
621,629
+60,332
| +11% | +$18.3M | 0.11% | 145 |
|
|
2019
Q3 | $163M | Sell |
561,297
-106,035
| -16% | -$30.4M | 0.1% | 156 |
|
|
2019
Q2 | $196M | Buy |
667,332
+248,387
| +59% | +$68.4M | 0.12% | 135 |
|
|
2019
Q1 | $115M | Buy |
418,945
+16,910
| +4% | +$4.21M | 0.08% | 202 |
|
|
2018
Q4 | $90M | Sell |
402,035
-227,012
| -36% | -$53.3M | 0.07% | 213 |
|
|
2018
Q3 | $154M | Sell |
629,047
-134,537
| -18% | -$31M | 0.11% | 144 |
|
|
2018
Q2 | $158M | Sell |
763,584
-45,210
| -6% | -$9.6M | 0.14% | 118 |
|
|
2018
Q1 | $167M | Sell |
808,794
-302,462
| -27% | -$63.5M | 0.13% | 131 |
|
|
2017
Q4 | $211M | Buy |
1,111,256
+600,015
| +117% | +$115M | 0.17% | 103 |
|
|
2017
Q3 | $96.7M | Buy |
511,241
+203,459
| +66% | +$36.8M | 0.1% | 159 |
|
|
2017
Q2 | $53.7M | Sell |
307,782
-16,694
| -5% | -$2.8M | 0.06% | 260 |
|
|
2017
Q1 | $49.8M | Buy |
324,476
+61,306
| +23% | +$9.37M | 0.05% | 252 |
|
|
2016
Q4 | $37.1M | Buy |
263,170
+79,818
| +44% | +$11.8M | 0.04% | 348 |
|
|
2016
Q3 | $29.2M | Sell |
183,352
-263,118
| -59% | -$40.5M | 0.03% | 407 |
|
|
2016
Q2 | $66M | Buy |
446,470
+133,282
| +43% | +$19.7M | 0.09% | 194 |
|
|
2016
Q1 | $44.2M | Sell |
313,188
-23,540
| -7% | -$3.15M | 0.07% | 249 |
|
|
2015
Q4 | $47.5M | Buy |
336,728
+27,904
| +9% | +$3.72M | 0.06% | 295 |
|
|
2015
Q3 | $37.7M | Sell |
308,824
-347,026
| -53% | -$45.2M | 0.05% | 351 |
|
|
2015
Q2 | $84.6M | Buy |
655,850
+361,831
| +123% | +$47.2M | 0.1% | 175 |
|
|
2015
Q1 | $39.4M | Sell |
294,019
-8,510
| -3% | -$1.1M | 0.05% | 399 |
|
|
2014
Q4 | $37.8M | Sell |
302,529
-69,126
| -19% | -$8.41M | 0.04% | 454 |
|
|
2014
Q3 | $45M | Buy |
371,655
+150,143
| +68% | +$18.3M | 0.04% | 358 |
|
|
2014
Q2 | $26.1M | Sell |
221,512
-111,890
| -34% | -$13.2M | 0.03% | 562 |
|
|
2014
Q1 | $40M | Sell |
333,402
-1,294,693
| -80% | -$154M | 0.05% | 370 |
|
|
2013
Q4 | $181M | Buy |
1,628,095
+642,585
| +65% | +$63.9M | 0.19% | 72 |
|
|
2013
Q3 | $90.7M | Buy |
985,510
+103,027
| +12% | +$9.32M | 0.11% | 137 |
|
|
2013
Q2 | $74.7M | Buy |
+882,483
| New | +$73.5M | 0.09% | 165 |
|
Other funds holding TMO
Barclays's TMO Position: Q2 2026 in Review
Barclays reduced its Thermo Fisher Scientific (TMO) stake by 27% in Q2 2026, selling an estimated $235M and leaving 1,354,112 shares worth $679M. The position accounts for 0.13% of the portfolio, ranked #97.
Barclays first reported a position in TMO in Q2 2013 and has held it in 53 quarters since. The position peaked at $1.06B in Q3 2024. 2,602 funds tracked by Wall St. Rank hold TMO as of Q2 2026.
- Barclays held 1,354,112 shares of Thermo Fisher Scientific worth $679M as of Q2 2026.
- Barclays sold 489,971 Thermo Fisher Scientific shares in Q2 2026, an estimated $235M.
- Thermo Fisher Scientific made up 0.13% of Barclays's portfolio in Q2 2026, its #97 holding.
- Barclays first reported a position in Thermo Fisher Scientific in Q2 2013 and has held it in 53 quarters since.
- Barclays's Thermo Fisher Scientific position peaked at $1.06B in Q3 2024.
- 2,602 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.
Based on Barclays's 13F filing for Q2 2026, filed 14 Aug 2026.